NCT06654193: Allogeneic HB-adMSCs vs Placebo for the Treatment of Acute Kidney Injury |
|
|
| Not yet recruiting | 1/2 | 70 | US | Allogeneic HB-adMSCs, Normal Saline | Hope Biosciences, The University of Texas Health Science Center, Houston, University of California, San Francisco, University of Alabama at Birmingham | Acute Kidney Injury | 01/28 | 01/28 | | |
NCT06526858: Early Feasibility Study of "HyperQureTM RDN System", Laparoscopic Renal Denervation Therapy, in Patients With Resistant Hypertension |
|
|
| Not yet recruiting | N/A | 15 | US | HyperQureTM Renal Denervation (RDN) System:, Extravascular renal denervation, Laparoscopic renal denervation | DeepQure Inc. | Resistant Hypertension | 08/25 | 05/28 | | |